ABcann Global Corporation (TSXV:ABCN) (the “Company”) is pleased to announce the appointment of W. Brett Wilson to the Advisory Board of the Company in connection with the completion of the Company’s acquisition of ABcann Medicinals Inc. (the “Transaction”). The Transaction included concurrent capital raises of $26.8 million to expand ABcann’s production capacity.

Mr. Wilson’s extensive experience and track record in financing and building early stage ventures into successful companies makes him an ideal strategic advisor to the Company at this stage of its development. Mr. Wilson was a co-founder in 1993 of the highly regarded investment bank, FirstEnergy (which was subsequently acquired by GMP Capital Inc.). He is a leading TV personality, known for his role as a “Dragon” on CBC’s award winning Dragons’ Den television program, and an early-stage venture financier in hundreds of successful companies.


Mr. Wilson’s involvement and $500,000 investment in the Company’s subscription receipt offering undertaken concurrently with the completion of the Transaction represents another major step for Mr. Wilson into the legal cannabis industry. He is also a lead investor and strategic advisor with Green Acre Capital, a Toronto and Calgary based cannabis industry focused investment fund.

“Mr. Wilson is a welcome addition to the Company’s Advisory Board. He’s a widely respected, established, and accomplished business leader and will complement the talents of our directors and advisors. We look forward to utilizing Brett’s knowledge and experiences as we grow the ABcann brand and welcome his personal investment and interest into the Company,” says Aaron Keay, CEO and a director of the Company.

ON BEHALF OF THE BOARD OF DIRECTORS

“Aaron Keay”
Aaron Keay
CEO and Director

For further information, please contact Aaron Keay by phone at (604) 323-6911 or by email aaron@abcannglobal.com OR Leo Karabelas by phone at 416 543-3120 or by email leo.k@abcannglobal.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which are statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to the timing of the resumption of trading of the Company’s shares on the TSXV and the expected contributions of Mr. Wilson. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including that delays may occur in timing of the resumption of trading and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the filing statement filed by the Company in connection with the Transaction, carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

Click here to connect with ABcann Global (TSX-V:ABCN) to receive an Investor Presentation.

Source: globenewswire.com

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced Boris Jordan Curaleaf Executive Chairman, will participate in Cantor Fitzgerald’s cannabis focused “Weednesday Series” investor fireside chat on June 30, 2021 at 11:00 am ET .

The event will be hosted by Pablo Zuanic , Managing Director, U.S. Consumer and Cannabis Equity Analyst at Cantor Fitzgerald and will be webcast live. To access the fireside chat webcast, please visit the investor relations section of the Curaleaf website, under the events tab, at https://ir.curaleaf.com/events .

Keep reading... Show less

Code Investment Love Hemp Announces Major Deal that Will See Anthony Joshua as Brand Ambassador and Collaborator on Licensed Range of CBD Products for Athletes

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s investment, Love Hemp Group Plc. has signed a major endorsement agreement with World Heavyweight Champion, Anthony Joshua, (https:twitter.comanthonyjoshua

Keep reading... Show less

Canbud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“Canbud” or the “Corporation”) is pleased to announce that its subsidiary Empathy Plant Co. has joined Plant-Based Foods of Canada (PBFC).

PBFC was founded in 2018 and has since acted as the collective voice of plant-based food companies. As a division of Food, Health & Consumer Products of Canada (FHCP), they work to keep consumers, governments and industry participants informed about the benefits of plant-based foods. The goal of PBFC is to move regulations forward to support innovation, growth and make plant-based eating more available to the masses.

Keep reading... Show less

 Trulieve Cannabis Corp. (” Trulieve ” or the ” Company “) (CSE: TRUL) (OTC: TCNNF) and Harvest Health & Recreation Inc. (” Harvest “) (CSE: HARV) (OTCQX: HRVSF) today  announced the expiration of the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) in connection with the previously announced proposed acquisition (the “Transaction”).

Trulieve CEO Kim Rivers commented, “Completion of the HSR milestone is exciting and we will continue to work toward closing this strategic transaction. Upon closing, we expect to leverage the expertise and resources of the combined companies to realize meaningful scale and expansion for years to come.”

Keep reading... Show less

Little Green Pharma Ltd (ASX: LGP) has acquired a world-class, fully-operational, GMP medicinal cannabis cultivation and manufacturing facility in Denmark from Canopy Growth Corporation (TSX:WEED, NASDAQ: CGC).

The facility, located in Northern Odense , has the capacity to produce in excess of 12 tonnes per annum of finished flower and provides LGP with much-needed product supply from its current inventory of ~1 tonne of medicinal cannabis flower products.

Keep reading... Show less